Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corneal Crosslinking Protocols in Keratoconus
NCT04427956Phase 4Completed
- Sponsor
- Region Skåne
- Start
- May 2017
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of riboflavin in keratoconus, sponsored by Region Skåne. Started May 2017; status: completed.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT04427956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427956.